Description

3-(5,6-Dibromo-1,3-Dioxooctahydro-2H-4,7-Methanoisoindol-2-Yl)Benzoic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex, functionalized isoindole core. This compound matters for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting central nervous system and metabolic disorders. Pharmaceutical R&D teams and fine chemical manufacturers need this specialized intermediate to develop next-generation therapeutics with enhanced efficacy and selectivity.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug molecules, especially those with bridged polycyclic structures.
• Organic Synthesis Building Block: Utilized in research and development for constructing novel heterocyclic compounds and exploring new chemical spaces in medicinal chemistry.
• Ligand and Catalyst Development: Serves as a starting material for creating specialized ligands or organocatalysts due to its rigid, functionalized architecture.
• Agrochemical Research: Investigated as an intermediate for developing new crop protection agents with unique modes of action.
• Material Science Precursor: Potential use in the synthesis of specialty polymers or organic electronic materials requiring specific brominated motifs.

Basic Information

Product Name	3-(5,6-Dibromo-1,3-Dioxooctahydro-2H-4,7-Methanoisoindol-2-Yl)Benzoic Acid
CAS No.	101758-77-4
Molecular Formula	C₁₆H₁₃Br₂NO₄
Molecular Weight	443.09 g/mol
Synonyms	3-[(5,6-Dibromo-1,3-dioxo-2,3,3a,4,7,7a-hexahydro-1H-4,7-methanoisoindol-2-yl)]benzoic acid; Benzoic acid, 3-(5,6-dibromo-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl)-; 2-(3-Carboxyphenyl)-5,6-dibromo-1,3-dioxo-2,3,3a,4,7,7a-hexahydro-1H-4,7-methanoisoindole; 5,6-Dibromo-2-(3-carboxyphenyl)hexahydro-4,7-methano-2H-isoindole-1,3-dione
EINECS	Contact for details

Quality Control

Our 3-(5,6-Dibromo-1,3-Dioxooctahydro-2H-4,7-Methanoisoindol-2-Yl)Benzoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and IR spectroscopy, to ensure compliance with exacting standards for pharmaceutical intermediates. Certificates of Analysis (COA) detailing all specifications are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (15-25°C). The compound may be light-sensitive; prolonged exposure to light should be avoided. Keep away from strong oxidizing agents and bases.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.